Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2538
+0.01144.70%
Post-market: 0.2521-0.0017-0.67%18:42 EDT
Volume:544.49K
Turnover:136.40K
Market Cap:67.27M
PE:-0.87
High:0.2559
Open:0.2447
Low:0.2424
Close:0.2424
Loading ...

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

Adaptimmune Therapeutics Plc - CFO Gavin Wood's Termination Date Extended to August 31, 2025 - SEC Filing

THOMSON REUTERS
·
15 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

Adaptimmune downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
12 Apr

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading

MT Newswires Live
·
11 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Adaptimmune Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Adaptimmune Therapeutics Plc : H.c. Wainwright Cuts Target Price to $3 From $3.5

THOMSON REUTERS
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live
·
28 Mar

Barclays Remains a Sell on Adaptimmune Therapeutics (ADAP)

TIPRANKS
·
27 Mar

Adaptimmune Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
26 Mar

Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $1.75 From $3

THOMSON REUTERS
·
26 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

Adaptimmune Therapeutics (ADAP) Gets a Buy from Scotiabank

TIPRANKS
·
25 Mar

ADAP 4Q24 Earnings Review: EPS Miss on 1x Restructuring/Impairment Costs; Potential Capital Raise Adds Risk to the Story

Zacks Small Cap Research
·
25 Mar

BRIEF-Adaptimmune Therapeutics PLC - Enters Amendment To Loan And Security Agreement - SEC Filing

Reuters
·
25 Mar

Adaptimmune Therapeutics Plc - to Make $25 Mln Loan Prepayment - SEC Filing

THOMSON REUTERS
·
25 Mar

Adaptimmune Therapeutics Plc : Scotiabank Cuts Target Price to $1.4 From $3.15

THOMSON REUTERS
·
21 Mar

Adaptimmune Therapeutics PLC (ADAP) (Q4 2024) Earnings Call Highlights: Strategic Growth and ...

GuruFocus.com
·
21 Mar